MIKHAILE RAMOS: Open Payments
NPI 1639500085 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 18 payments from 11 companies in 2025. Trend: 2023 $519 · 2024 $515 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $87 |
| Teva Pharmaceuticals USA, Inc. | 1 | $68 |
| Lilly USA, LLC | 3 | $49 |
| Exact Sciences Corporation | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: Omnipod, CAPLYTA, UZEDY, MOUNJARO, Cologuard Collection Kit, INGREZZA, YUPELRI, Veozah.
Industry payments across NM — which companies pay providers there.
